ArticleHematology, transfusion and cell therapy2021

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma.

Alvaro J Alencar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.